Polymeric inhibitors of platelet aggregation. II. Copolymers of dipyridamole and related drugs with N-vinylpyrrolidone

This publication has 16 references indexed in Scilit:

• Polymeric inhibitors of platelet aggregation. Synergistic effects and proposals for a new mechanism
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1986
• Pharmacokinetics of oral dipyridamole (Persantine ) and its effect on platelet adenosine uptake in man
  European Journal of Clinical Pharmacology, 1982
• Mode of action of dipyridamole on human platelets
  Thrombosis Research, 1979
• Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species
  Prostaglandins, 1978
• DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLIN
  The Lancet, 1978
• Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: Possible explanation of mechanism of inhibition of platelet function
  Life Sciences, 1975
• Human brain and platelet cyclic adenosine 3′,5′-monophosphate phosphodiesterases: Different response to drugs
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1972
• Species differences in action and elimination of adenosine after dipyridamole and hexobendine
  European Journal of Pharmacology, 1971
• EFFECT OF DIPYRIDAMOLE ON HUMAN PLATELET BEHAVIOUR
  The Lancet, 1965
• Influence of a Pyrimidopyrimidine Derivative on Deamination of Adenosine by Blood
  Circulation Research, 1964